SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-19-048197
Filing Date
2019-08-30
Accepted
2019-08-30 12:26:06
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 a19-18046_1s3.htm S-3 653304
2 EX-1.2 a19-18046_1ex1d2.htm EX-1.2 246349
3 EX-5.1 a19-18046_1ex5d1.htm EX-5.1 62661
4 EX-5.2 a19-18046_1ex5d2.htm EX-5.2 15942
5 EX-23.1 a19-18046_1ex23d1.htm EX-23.1 2334
6 GRAPHIC g180461bei001.gif GRAPHIC 3749
7 GRAPHIC g180461kgi001.jpg GRAPHIC 2885
8 GRAPHIC g180461bwi001.jpg GRAPHIC 4423
9 GRAPHIC g180461boi001.gif GRAPHIC 3172
  Complete submission text file 0001104659-19-048197.txt   1001915
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-233557 | Film No.: 191068770
SIC: 2836 Biological Products, (No Diagnostic Substances)